Vascular Biogenics Ltd. Contracts & Agreements
41 Contracts & Agreements
- Business Finance (20 contracts)
- Business Operations (4)
- Human Resources (6)
- Intellectual Property (1)
- Real Estate (2)
- Uncategorized (8)
- Form of Securities Purchase Agreement (Filed With SEC on August 29, 2024)
- Form of Placement Agency Agreement (Filed With SEC on August 29, 2024)
- Form of Warrant Agency Agreement (Filed With SEC on August 29, 2024)
- Form of Tranche A Ordinary Warrant (Filed With SEC on August 29, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on August 29, 2024)
- Form of Tranche A Ordinary Warrant (Filed With SEC on August 26, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on August 26, 2024)
- Form of Tranche B Ordinary Warrant (Filed With SEC on August 26, 2024)
- Form of Warrant Agency Agreement (Filed With SEC on August 26, 2024)
- Form of Placement Agency Agreement (Filed With SEC on August 26, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on August 26, 2024)
- Second Amended and Restated Employment Agreement with Thomas Bock dated August 9, 2024 (Filed With SEC on August 14, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on July 1, 2024)
- Form of Placement Agency Agreemen (Filed With SEC on July 1, 2024)
- Form of Warrant Agency Agreement (Filed With SEC on July 1, 2024)
- Form of Tranche B Ordinary Warrant (Filed With SEC on July 1, 2024)
- Form of Tranche A Ordinary Warrant (Filed With SEC on July 1, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on July 1, 2024)
- Form of Release and Indemnification Agreement (Filed With SEC on October 16, 2023)
- Press Release, dated October 12, 2023 (Filed With SEC on October 12, 2023)
- Asset Purchase Agreement between Vascular Biogenics Ltd. and Wellbeing Group Ltd., dated October 1, 2023 (Filed With SEC on October 2, 2023)
- Form of Stock Option Award Agreement between Notable Labs, Inc. and purchasers of Series C-1 Preferred Stock, dated June 2021 (Filed With SEC on May 11, 2023)
- Form of Support Agreement, by and between Vascular Biogenics Ltd. and Notable Labs, Inc. and certain directors and officers of Notable Labs, Inc (Filed With SEC on May 11, 2023)
- Form of Support Agreement, by and between Vascular Biogenics Ltd., Notable Labs, Inc., and certain directors and officers of Vascular Biogenics Ltd (Filed With SEC on May 11, 2023)
- Form of Lock-Up Agreement, by and among Notable Labs, Inc., Vascular Biogenics Ltd., and certain directors and officers of Notable Labs, Inc (Filed With SEC on May 11, 2023)
- Form of Lock-Up Agreement, by and among Notable Labs, Inc., Vascular Biogenics Ltd., and certain directors and officers of Vascular Biogenics Ltd (Filed With SEC on May 11, 2023)
- Exclusive License Agreement by and between Notable Labs, Inc. and Oncoheroes Biosciences Inc. dated October 1, 2021 (Filed With SEC on May 11, 2023)
- Side Letter by and between Boehringer Ingelheim International GmbH and Oncoheroes Biosciences Inc. dated August 1, 2019, as amended by Amendment #1 effective on April 5, 2020 (Filed With SEC on May 11, 2023)
- Co-Development and Profit-Sharing Agreement between Notable Labs, Inc. and CicloMed LLC dated July 20, 2021 (Filed With SEC on May 11, 2023)
- Standard Industrial/Commercial Single-Tenant Lease by and between Hatch Drive Associates and the Notable Labs, Inc., dated as of March 25, 2019 (Filed With SEC on May 11, 2023)
- First Amendment to Lease Agreement by and between Hatch Drive Associates, LLC and Notable Labs, Inc., dated as of April 27, 2023 (Filed With SEC on May 11, 2023)
- Amended and Restated Employment Agreement by and between Notable Labs, Inc. and Thomas Bock dated April 30, 2021 (Filed With SEC on May 11, 2023)
- Employment Agreement by and between Notable Labs, Inc. and Joseph Wagner dated June 15, 2020 (Filed With SEC on May 11, 2023)
- Engagement Letter by and between Notable Labs, Inc. and Scott A. McPherson dated March 1, 2023 (Filed With SEC on May 11, 2023)
- 2015 Stock Plan of Notable Labs, Inc (Filed With SEC on May 11, 2023)
- Form of Series C Warrant Agreement between Notable Labs, Inc. and purchasers of Series C-1 Preferred Stock, dated June 2021 (Filed With SEC on May 11, 2023)
- Asset Purchase Agreement, dated as of February 15, 2023, by and between the Registrant and Aleph Farms Ltd (Filed With SEC on March 14, 2023)
- Employment Offer Letter between the Registrant and Sam Backenroth, dated October 4, 2021 (Filed With SEC on March 14, 2023)
- Restated Consulting and Services Agreement between the Registrant and Grand H Services Ltd., dated January 20, 2022, as amended on August 23, 2022 (Filed With SEC on March 14, 2023)
- Restated Executive Employment Agreement between the Registrant and Dror Harats, dated January 20, 2022 (Filed With SEC on March 14, 2023)
- Description of Securities (Filed With SEC on March 14, 2023)
